KDR and neoplasm: However, prior work showed that the efficacy of an anti-angiogenic Lm-based vaccine targeting the vascular antigen VEGFR2 was dependent on epitope spreading to tumor-associated antigens as responses to tumor vasculature alone were insufficient (45).Importantly, Saroufim et al.